Role of Resistance Testing, Adverse Effects of Therapy and Drug-Drug Interactions

Module number
 
Date presented
October 8, 2019 
Duration
1:00 
Audience
 
CE Credit
ELF 

On Tuesday, October 8th 2019, Dr. Tatyana Kushner of Icahn School of Medicine at Mount Sinai presented on:

“Role of Resistance Testing, Adverse Effects of Therapy and Drug-Drug Interactions”

Learning Objectives:

  1. Describe the basics of Hepatitis C Virus (HCV) virology
  2. Explain the direct acting antiviral therapy targets and agents
  3. Describe resistance to HCV therapies
  4. Describe the role of resistance testing in HCV therapy

Presenter Bio:

Tatyana Kushner, MD, MSCE is a faculty member in the division of Liver Diseases at Icahn School of Medicine at Mount Sinai. She completed her medical school and internal medicine training at Mount Sinai, a fellowship in gastroenterology and masters in clinical epidemiology at the University of Pennsylvania, and a fellowship in transplant hepatology at University of California, San Francisco. Her research and clinical interests are in viral hepatitis as well as women’s health and liver disease, with a particular focus on viral hepatitis in pregnancy.

Access the slides here